Shandong Yanggu Huatai Chemical Co., Ltd. (SHE:300121)
China · Delayed Price · Currency is CNY 12.94
+0.32 (2.54%)
Apr 17, 2026, 1:45 PM CST
SHE:300121 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,429 | 3,415 | 3,445 | 3,502 | 2,690 |
Other Revenue | 13.96 | 15.99 | 9.2 | 14.94 | 15.54 |
| 3,443 | 3,431 | 3,455 | 3,517 | 2,705 | |
Revenue Growth (YoY) | 0.37% | -0.69% | -1.78% | 30.01% | 39.20% |
Cost of Revenue | 2,863 | 2,824 | 2,683 | 2,556 | 2,090 |
Gross Profit | 580.85 | 607.28 | 771.17 | 961.42 | 615.76 |
Selling, General & Admin | 232.58 | 238.84 | 246.95 | 256.3 | 167.77 |
Research & Development | 81.09 | 88.63 | 84.33 | 78.52 | 77.67 |
Other Operating Expenses | 26.37 | 25.46 | 22.46 | 24.65 | 15.74 |
Operating Expenses | 334.2 | 367.5 | 358.87 | 363.37 | 261.31 |
Operating Income | 246.65 | 239.79 | 412.29 | 598.06 | 354.45 |
Interest Expense | -23.89 | -41.34 | -26.4 | -15.14 | -17.02 |
Interest & Investment Income | 17.54 | 15.66 | 8.95 | 7.22 | 3.42 |
Currency Exchange Gain (Loss) | 0.16 | 11.2 | 14.66 | 41.91 | -10.87 |
Other Non Operating Income (Expenses) | -1.19 | 4.83 | -10.57 | -2.45 | -2.71 |
EBT Excluding Unusual Items | 239.28 | 230.12 | 398.94 | 629.6 | 327.27 |
Gain (Loss) on Sale of Investments | 0.06 | -0.04 | -0.92 | 1.03 | 10.09 |
Gain (Loss) on Sale of Assets | -0.34 | 0.42 | - | -0.05 | -0.31 |
Asset Writedown | -9.35 | -4.96 | -2.36 | -7.42 | -1.41 |
Other Unusual Items | 34.61 | 11.9 | -14.3 | 3.96 | 12.6 |
Pretax Income | 264.26 | 237.45 | 381.36 | 627.13 | 348.24 |
Income Tax Expense | 65.36 | 45.2 | 77.06 | 111.74 | 64.32 |
Earnings From Continuing Operations | 198.89 | 192.24 | 304.3 | 515.39 | 283.92 |
Minority Interest in Earnings | -1.55 | -0.12 | -0 | - | - |
Net Income | 197.34 | 192.13 | 304.3 | 515.39 | 283.92 |
Net Income to Common | 197.34 | 192.13 | 304.3 | 515.39 | 283.92 |
Net Income Growth | 2.72% | -36.86% | -40.96% | 81.52% | 125.73% |
Shares Outstanding (Basic) | 439 | 409 | 406 | 385 | 369 |
Shares Outstanding (Diluted) | 439 | 409 | 417 | 385 | 374 |
Shares Change (YoY) | 7.28% | -1.94% | 8.38% | 2.95% | 0.98% |
EPS (Basic) | 0.45 | 0.47 | 0.75 | 1.34 | 0.77 |
EPS (Diluted) | 0.45 | 0.47 | 0.73 | 1.34 | 0.76 |
EPS Growth | -4.25% | -35.62% | -45.52% | 76.32% | 123.53% |
Free Cash Flow | 60.26 | 10.4 | 5.26 | 163.24 | 11.41 |
Free Cash Flow Per Share | 0.14 | 0.03 | 0.01 | 0.42 | 0.03 |
Dividend Per Share | 0.150 | 0.190 | 0.250 | 0.200 | 0.100 |
Dividend Growth | -21.05% | -24.00% | 25.00% | 100.00% | -33.33% |
Gross Margin | 16.87% | 17.70% | 22.32% | 27.33% | 22.76% |
Operating Margin | 7.16% | 6.99% | 11.94% | 17.00% | 13.10% |
Profit Margin | 5.73% | 5.60% | 8.81% | 14.65% | 10.50% |
Free Cash Flow Margin | 1.75% | 0.30% | 0.15% | 4.64% | 0.42% |
EBITDA | 456.48 | 425.91 | 562.13 | 729.27 | 471.44 |
EBITDA Margin | 13.26% | 12.41% | 16.27% | 20.73% | 17.43% |
D&A For EBITDA | 209.83 | 186.12 | 149.84 | 131.21 | 116.99 |
EBIT | 246.65 | 239.79 | 412.29 | 598.06 | 354.45 |
EBIT Margin | 7.16% | 6.99% | 11.94% | 17.00% | 13.10% |
Effective Tax Rate | 24.73% | 19.04% | 20.21% | 17.82% | 18.47% |
Revenue as Reported | 3,443 | 3,431 | 3,455 | 3,517 | 2,705 |
Advertising Expenses | 2.21 | 1.96 | 1.33 | 0.73 | 3.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.